Synapse - Sujata Patil

Results (511)

Histologic determinants of long-term overall survival in patients (pts) with germ cell tumors (GCT)

Meeting Abstract

Funt, S.; Patil, S.; Feldman, D. R.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.; Tickoo, S.; Reuter, V. E.; Bosl, G. J.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Institutional variation in the thoroughness of pathologic assessment and pathologic complete response rates for locally advanced rectal cancers treated with neoadjuvant chemoradiation

Meeting Abstract

Chow, O. S.; Patil, S.; Keskin, M.; Smith, J. J.; Widmar, M.; Smith, D. D.; Avila, K.; Shia, J.; Chu, P. G.; Garcia-Aguilar, J.
Journal of Clinical Oncology (2017)

Fulltext@MSK | Save

Genomic characterization of renal medullary carcinoma and treatment outcomes

Journal Article

Carlo, M. I.; Chaim, J.; Patil, S.; Kemel, Y.; Schram, A. M.; Woo, K.; Coskey, D.; Nanjangud, G. J.; Voss, M. H.; Feldman, D. R.; more...
Clinical Genitourinary Cancer (2017)

Fulltext@MSK | Save

Quantifying the incidence of homologous recombination repair status in metastatic triple negative breast cancer receiving concurrent cisplatin and radiation therapy

Meeting Abstract

Powell, S. N.; Gucalp, A.; Traina, T. A.; Patil, S.; Wilgucki, M.; Arnold, B. B.; Cahlon, O.; Delsite, R.; Ulaner, G. A.; Ho, A. Y.
International Journal of Radiation Oncology, Biology, Physics (2017)

Fulltext@MSK | Save

Outcomes for women with minimal-volume ductal carcinoma in situ completely excised at core biopsy

Journal Article

Muhsen, S.; Barrio, A. V.; Miller, M.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
Annals of Surgical Oncology (2017)

Fulltext@MSK | Save

Designing trials that aim to evaluate therapies that target brain metastases in cancer patients: Challenges and recommendations

Meeting Abstract

Patil, S.
Trials (2017)

Fulltext@MSK | Save

Contralateral breast cancer risk in women with ductal carcinoma in situ: Is it high enough to justify bilateral mastectomy?

Journal Article

Miller, M. E.; Muhsen, S.; Olcese, C.; Patil, S.; Morrow, M.; Van Zee, K. J.
Annals of Surgical Oncology (2017)

Fulltext@MSK | Save

A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer

Journal Article

Jhaveri, K.; Wang, R.; Teplinsky, E.; Chandarlapaty, S.; Solit, D.; Cadoo, K.; Speyer, J.; D'Andrea, G.; Adams, S.; Patil, S.; more...
Breast Cancer Research (2017)

Fulltext@MSK | Save

Standard pathologic features can be used to identify a subset of estrogen receptor-positive, HER2 negative patients likely to benefit from neoadjuvant chemotherapy

Journal Article

Petruolo, O. A.; Pilewskie, M.; Patil, S.; Barrio, A. V.; Stempel, M.; Wen, H. Y.; Morrow, M.
Annals of Surgical Oncology (2017)

Fulltext@MSK | Save

Axillary dissection and nodal irradiation can be avoided for most node-positive Z0011-eligible breast cancers: A prospective validation study of 793 patients

Journal Article

Morrow, M.; Van Zee, K. J.; Patil, S.; Petruolo, O.; Mamtani, A.; Barrio, A. V.; Capko, D.; El-Tamer, M.; Gemignani, M. L.; Heerdt, A. S.; more...
Annals of Surgery (2017)

Fulltext@MSK | Save